Skip to content
Independent analysis of NHS open data
PharmaInsight

Rituximab

Malignant Disease and Immunosuppression Drugs affecting the immune response BNF 0802030F0
Data updated December 2025 Download CSV
1items

Dispensed in December 2025

3items

Rolling 12 months

£175

Net ingredient cost · December 2025

Figure 1. Rituximab: national items dispensed by month

0 1 2 Apr 2021 May 2022 May 2023 Jan 2024 Jun 2025 Dec 2025 1 Apr 2021: 1 Feb 2022: 1 May 2022: 1 Feb 2023: 1 May 2023: 1 Jul 2023: 1 Jan 2024: 2 Aug 2024: 1 Jun 2025: 1 Nov 2025: 1 Dec 2025: 1

Source: NHSBSA Prescription Cost Analysis, to December 2025

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs affecting the immune response
  • Presentations 1 shown
  • Average cost / item £174.63
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, December 2025

The individual products dispensed under Rituximab this month.

Presentations of Rituximab, December 2025
Presentation BNF code Items Net ingredient cost
Ituxredi 100mg/10ml concentrate for inf vials 0802030F0BFABAB 1 £175

Source: NHSBSA Prescription Cost Analysis · to December 2025 OGL v3.0

Where Rituximab is dispensed

The regions and dispensing practices with the highest Rituximab volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Rituximab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Rituximab with

Other medicines in the same BNF section, by prescribing volume.